
2007-04-19
Microscopic
0personInquired
0personFavorited
ConnectType:
T - Technology & Patents
Industry:
New Materials and Polymer MaterialsFine Chemical Manufacturing
Country / Region:
China
Company Type:
OtherListed companySpecialized refined distinctive and innovative enterprises
Registered Capital:
RMB 35,004,588.79
Company Capability: Chemical Technology & Patents、Process Technology Development、Technology Transfer
Changchun Sinobiom Biological Materials Co.,Ltd. is a national high-tech enterprise specializing in the research, development, production, and sales of biodegradable medical polymer materials. Positioned at the forefront of biomedical materials, the company is dedicated to providing clinicians with safe, controllable, and functionally matched absorbable solutions. Its core business encompasses the synthesis, modification, and end-application development of bioabsorbable materials—including polylactic acid (PLA), polycaprolactone (PCL), polyglycolic acid (PGA), and their copolymers—whose products are widely applied in orthopedics, neurosurgery, oral and maxillofacial surgery, tissue engineering scaffolds, and drug sustained-release carriers. Leveraging an independent R&D laboratory and a GMP-compliant pilot-scale manufacturing facility, the company possesses full-chain technical capabilities spanning material design, process optimization, and performance validation. It holds 12 valid invention patents and 8 utility model patents; it led the drafting of the standard “DB22/T 3621—2024 Technical Requirements for Degradable Medical Polylactic Acid Particles” and participated in formulating the industry standard “YY/T 1871—2023.” The company holds the “Medical Device Production License” (Jilin Food and Drug Administration Medical Device Production Permit No. 20220067), and its Class II medical device products have completed filing with the Jilin Provincial Medical Products Administration. Its quality management system complies with YY/T 0287—2017 (ISO 13485:2016). The company has initiated clinical collaborations and animal experimental studies with institutions including the First Hospital of Jilin University and the First Affiliated Hospital of China Medical University. Its core materials serve over 20 Grade-III hospitals across Northeast, North, and East China, as well as 12 provincial-level medical device testing and inspection institutions. Currently, the company offers multidimensional collaboration opportunities—including material customization, joint development, clinical translation support, and regional product supply—to healthcare institutions, scientific research institutes, medical device manufacturers, and channel partners.
Connect
More Suppliers科林能源技术(北京)有限公司
77
0
T - Technology & Patents
E - Engineering Design
P - Procurement
S - Site & Revamp
凯铭科技(杭州)有限公司
79
0
T - Technology & Patents
P - Procurement
Dalian Pace Gas Equipment Co., Ltd.
112
0
T - Technology & Patents
E - Engineering Design
P - Procurement
S - Site & Revamp





































